Predictive value of comorbidity and anemia on outcome in patients with sinonasal carcinoma
Journal of Cranio-Maxillofacial Surgery May 15, 2018
Becker C, et al. - Authors sought to scrutinize the impact of comorbidities and anemia on the outcome and survival in cases with sinonasal carcinomas by appraising medical records of 121 patients with carcinoma treated at a single quaternary medical care and cancer center between 2002 and 2015. It was discovered that comorbidity presented as an independent risk factor on overall, disease-free and disease-specific survival in patients with sinonasal carcinoma. A connection was illustrated between anemia with shorter overall survival. This is the first study evaluating comorbidity using the age-adjusted Charlson comorbidity index (ACCI) scoring system and focusing on patients with sinonasal carcinoma.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries